Cost-effectiveness analysis of a first-trimester screening test for preterm preeclampsia in the Netherlands.

Beernink, Rik H J; Scherjon, Sicco A; Cremers, Thomas I F H; van Asselt, Antoinette D I

Beernink, Rik H J; Scherjon, Sicco A; Cremers, Thomas I F H; van Asselt, Antoinette D I.

Afiliação

Beernink RHJ; Dept. Analytical Biochemistry, University of Groningen, Groningen, the Netherlands; Research & Development, IQ Products BV., Groningen, the Netherlands. Electronic address: r.h.j.beernink@rug.nl.
Scherjon SA; Dept. of Obstetrics and Gynaecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Cremers TIFH; Dept. Analytical Biochemistry, University of Groningen, Groningen, the Netherlands.
van Asselt ADI; Dept. of Health Sciences, University of Groningen, University Medical Center, Groningen, the Netherlands; Dept. of Epidemiology, University of Groningen, University Medical Center, Groningen, the Netherlands.

J Reprod Immunol ; 160: 104141, 2023 12.

Article em En | MEDLINE | ID: mdl-37708725

Assuntos

Pré-Eclâmpsia; Gravidez; Recém-Nascido; Feminino; Humanos; Pré-Eclâmpsia/diagnóstico; Pré-Eclâmpsia/prevenção & controle; Primeiro Trimestre da Gravidez; Análise de Custo-Efetividade; Países Baixos; Aspirina/uso terapêutico

Palavras-chave

Cost-effectiveness analysis; Netherlands; Preterm preeclampsia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Newborn / Pregnancy País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google